Sitagliptin STADA
This medicine helps control high blood sugar levels in adults with type 2 diabetes by increasing insulin after meals and reducing the amount of sugar your body makes.
Form
tabletti, kalvopäällysteinen
Strength
50 mg
Active Ingredient
Sitagliptin hydrochloride monohydrate
Manufacturer
STADA Arzneimittel AG
How to Use
Dosage
The usual dose is one 100 mg tablet once a day. Your doctor may prescribe a lower dose if you have kidney problems.
Method
Take by mouth, with or without food and drink.
Important
Do not take more than 100 mg in a single day.
Possible Side Effects
COMMON
- •low blood sugar
- •nausea
- •flatulence
- •vomiting
- •stomach discomfort
- •constipation
- •swollen hands or feet
- •common cold
- •headache
- •upper respiratory infection
- •stuffy or runny nose and sore throat
- •osteoarthritis
- •pain in arms or legs
RARE
- •stomach pain
- •diarrhea
- •drowsiness
- •dry mouth
- •dizziness
- •itching
- •decreased platelet count
- •kidney problems
- •joint pain
- •muscle pain
- •back pain
- •interstitial lung disease
- •blistering skin condition (bullous pemphigoid)
Important Warnings
- Do not take this medicine if you are allergic to sitagliptin or any other ingredients.
- Stop taking this medicine and see a doctor right away if you get severe, lasting stomach pain, with or without vomiting, as this could be a sign of pancreatitis (inflammation of the pancreas).
- If you get blisters or peeling skin, tell your doctor, as this could be a serious skin reaction.
- If you take this medicine with insulin or a sulfonylurea, you may get low blood sugar. Your doctor might need to adjust your dose.
- This medicine is not for people with type 1 diabetes or diabetic ketoacidosis.
Show 2 more warnings
- Tell your doctor if you have or have had kidney problems.
- Do not use if you are under 18, pregnant, trying to get pregnant, or breastfeeding.
Use in Elderly Patients
Category C
Suitable for older adults, with specific precautions. Reduce the dose in moderately severe renal impairment. (updated 10.6.2024)